When it comes to treating autoimmune diseases, recognizing the symptoms early is key. Maybe you first heard about an ...

The incidence and prevalence of CTD-ILD in the US is most common among women and older individuals, affecting approximately 116,000 to 118,000 adults.

At the time the esophageal studies were performed 6 patients had active systemic disease, 6 had questionably active disease, and 4 were in remission. Other connective-tissue disorders.

EYSINS, Switzerland, April 3, 2025 /PRNewswire/ -- Today, AliveDx announces it has submitted 510 (k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ...

AliveDx announces US FDA 510 (k) submission for MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) multiplex microarray Provided by PR Newswire Apr 3, 2025, 5:00:00 AM ...

Among the group of 243 patients with granulomatous thyroiditis, only 3 (1.2 per cent) had Connective-Tissue symptoms or disease (Table 2). Only 1 had rheumatoid arthritis, an incidence of 0.4 per ...

Diagnosing these conditions is complex due to overlapping clinical symptoms and high rates of co-occurrence among a range of connective tissue diseases 1. This complexity often leads to delayed ...

The MosaiQ AiPlex CTDplus assay enables a syndromic approach and accurate serological evaluation of Rheumatoid Arthritis (RA) and connective tissue diseases (CTD) for healthcare providers. Its ...

Long-term monitoring and care of patients is crucial after COVID-19, considering demographic factors, disease severity, and vaccination status, to mitigate these risks.

Mixed connective tissue disease (MCTD) is a complex and relatively rare autoimmune disorder. It shares symptoms with lupus, systemic sclerosis, and myositis. MCTD is a challenging condition that ...